Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
424 studies found for:    "Idiopathic pulmonary hypertension"
Show Display Options
Download search resultsDownload the search results for:
"Idiopathic pulmonary hypertension" (424 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed The Early Recognition of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Device: ETED, CPET, RHC
2 Completed
Has Results
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: macitentan (ACT-064992);   Drug: placebo
3 Completed
Has Results
Coenzyme Q-10 and Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Dietary Supplement: Coenzyme Q-10 in Pulmonary Hypertension subjects;   Dietary Supplement: Coenzyme Q-10 in Normal Control subjects
4 Completed Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Fluoxetine
5 Completed 6R-BH4 Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sapropterin dihydrochloride (6R-BH4)
6 Completed
Has Results
Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Imatinib mesylate;   Drug: Placebo
7 Completed Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sorafenib
8 Unknown  Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Procedure: Resynchronization therapy of right ventricle
9 Terminated
Has Results
Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Imatinib;   Drug: Placebo
10 Completed
Has Results
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Selexipag;   Drug: Placebo
11 Withdrawn Patient Reported Outcomes in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Other: Interview;   Other: Questionnaire
12 Active, not recruiting ACT-293987 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: ACT-293987
13 Completed
Has Results
Epoprostenol for Injection in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ACT-385781A (Actelion Epoprostenol);   Drug: Flolan®
14 Terminated
Has Results
Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Iloprost PD-6;   Drug: Iloprost PD-15
15 Withdrawn Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Iloprost Inhalation Solution (Ventavis)
16 Unknown  Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Submaximal exercises
17 Completed
Has Results
Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ACT-385781A (Actelion Epoprostenol);   Drug: Flolan®
18 Active, not recruiting Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: BPS-314d-MR
19 Terminated Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Remodulin (treprostinil sodium)
20 Recruiting Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies
Condition: Idiopathic Pulmonary Arterial Hypertension
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.